SkyView Investment Advisors LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 73.1% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,000 shares of the healthcare conglomerate's stock after selling 2,719 shares during the period. SkyView Investment Advisors LLC's holdings in UnitedHealth Group were worth $416,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the 4th quarter valued at about $27,000. Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $29,000. Aberdeen Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Merkkuri Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth approximately $33,000. Institutional investors own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the topic of several recent research reports. Robert W. Baird upgraded UnitedHealth Group from an "underperform" rating to a "neutral" rating and increased their price objective for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 16th. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a report on Wednesday, May 27th. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the company an "outperform" rating in a research note on Wednesday, June 17th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $456.56.
View Our Latest Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.19% of the company's stock.
UnitedHealth Group Trading Up 1.1%
UNH opened at $383.23 on Tuesday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a market capitalization of $343.99 billion, a price-to-earnings ratio of 24.66, a P/E/G ratio of 1.43 and a beta of 0.61. The company has a 50-day simple moving average of $407.88 and a 200 day simple moving average of $369.08.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's payout ratio is currently 59.72%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.
UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.